A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

by | Jun 23, 2025 | Clinical Trials | 0 comments

​ Conditions: Advanced Malignant Tumors

Interventions: Drug: SSGJ-612

Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD.

Not yet recruiting Conditions: Advanced Malignant Tumors
Interventions: Drug: SSGJ-612
Sponsors: Shenyang Sunshine Pharmaceutical Co., LTD.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *